Annual D&A
$7.33M$3.25M-30.69%
Summary
- Current Value
- As of today, ROIV annual D&A is $7.33M, down -30.69% on
- Historical Performance
- ROIV annual D&A is up +23.60% over the past 3 years, with unknown 5-year change
- All-Time High Comparison
- ROIV annual D&A is currently -72.25% below its historical high of $26.42M set on
- 3-Year Low Comparison
- ROIV annual D&A is +23.60% above its 3-year low of $5.93M reached on an earlier date
- Sector Comparison
- ROIV annual D&A is higher than 68.15% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $7.33M | -30.7% | +23.6% | – | – | |
| Quarterly D&A | $921.00K | +200.2% | -81.8% | – | – | |
| TTM D&A | $5.39M | -38.9% | -50.3% | – | – | |
| Price | $23.40 | +111.4% | +137.1% | +128.4% | – | |
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual Total Expenses | $574.06M | +112.4% | -36.3% | -2.2% | -23.6% | |
| Annual Operating Expenses | $1.13B | +34.2% | -9.8% | +89.4% | +51.2% | |
| Annual Revenue | $29.05M | -11.2% | -47.5% | -57.1% | +1150.1% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $26.42M | -72.3% | |
| 5Y | $26.42M | -72.3% | |
| All | $26.42M | -72.3% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $5.93M | N/A | +23.6% |
| 5Y | $5.93M | +23.6% | |
| All | $5.93M | +23.6% |
Depreciation & Amortization History
| Year | Value | Change |
|---|---|---|
| $7.33M | -30.7% | |
| $10.58M | -60.0% |
| Year | Value | Change |
|---|---|---|
| $26.42M | +345.4% | |
| $5.93M | - |
FAQ
What is the current annual D&A of ROIV?
As of today, ROIV annual D&A is $7.33M
What is 1-year change in ROIV annual D&A?
ROIV annual D&A is down -30.69% year-over-year
What is 3-year change in ROIV annual D&A?
ROIV annual D&A is up +23.60% over the past 3 years
How far is ROIV annual D&A from its all-time high?
ROIV annual D&A is currently -72.25% below its historical high of $26.42M set on March 31, 2023
How does ROIV annual D&A rank versus sector peers?
ROIV annual D&A is higher than 68.15% of companies in Healthcare sector
When is ROIV next annual earnings release?
As of today, the next annual earnings release for ROIV has not been scheduled
Quarterly D&A
$921.00K$177.00K-16.12%
Summary
- Current Value
- As of today, ROIV quarterly D&A is $921.00K, down -16.12% on
- Historical Performance
- ROIV quarterly D&A is up +200.22% year-over-year, and down -81.85% over the past 3 years
- All-Time High Comparison
- ROIV quarterly D&A is currently -87.73% below its historical high of $7.51M set on
- 3-Year Low Comparison
- ROIV quarterly D&A is +153.05% above its 3-year low of -$1.74M reached on
- Sector Comparison
- ROIV quarterly D&A is higher than 57.55% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $921.00K | -16.1% | +200.2% | -81.8% | – | |
| Annual D&A | $7.33M | – | -30.7% | +23.6% | – | |
| TTM D&A | $5.39M | +51.9% | -38.9% | -50.3% | – | |
| Price | $23.40 | +37.7% | +111.4% | +137.1% | +128.4% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly Total Expenses | $115.09M | -49.0% | -39.9% | -62.2% | -78.1% | |
| Quarterly Operating Expenses | $306.77M | +7.3% | -11.3% | +5.9% | -44.8% | |
| Quarterly Revenue | $1.57M | -27.6% | -64.9% | -87.5% | -89.6% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.94M | N/A | -52.6% |
| 3Y | $7.51M | -87.7% | |
| 5Y | $7.51M | -87.7% | |
| All | $7.51M | -87.7% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $921.00K | at low | |
| 3Y | -$1.74M | +153.1% | |
| 5Y | -$1.74M | +153.1% | |
| All | -$1.74M | +153.1% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of ROIV?
As of today, ROIV quarterly D&A is $921.00K
What is ROIV quarterly D&A most recent change?
ROIV quarterly D&A was down -16.12% on September 30, 2025
What is 1-year change in ROIV quarterly D&A?
ROIV quarterly D&A is up +200.22% year-over-year
How far is ROIV quarterly D&A from its all-time high?
ROIV quarterly D&A is currently -87.73% below its historical high of $7.51M set on March 31, 2023
How does ROIV quarterly D&A rank versus sector peers?
ROIV quarterly D&A is higher than 57.55% of companies in Healthcare sector
When is ROIV next earnings release?
The next earnings release for ROIV is on
TTM D&A
$5.39M$1.84M+51.87%
Summary
- Current Value
- As of today, ROIV TTM D&A is $5.39M, up +51.87% on
- Historical Performance
- ROIV TTM D&A is down -38.92% year-over-year, and down -50.25% over the past 3 years
- All-Time High Comparison
- ROIV TTM D&A is currently -80.05% below its historical high of $27.01M set on
- 3-Year Low Comparison
- ROIV TTM D&A is +51.87% above its 3-year low of $3.55M reached on
- Sector Comparison
- ROIV TTM D&A is higher than 62.32% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $5.39M | +51.9% | -38.9% | -50.3% | – | |
| Annual D&A | $7.33M | – | -30.7% | +23.6% | – | |
| Quarterly D&A | $921.00K | -16.1% | +200.2% | -81.8% | – | |
| Price | $23.40 | +37.7% | +111.4% | +137.1% | +128.4% | |
| TTM SG&A | -$168.24M | -126.9% | -123.4% | -130.0% | -307.3% | |
| TTM Revenue | $20.33M | -12.5% | -45.1% | -59.7% | +34.2% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $8.24M | N/A | -34.7% |
| 3Y | $27.01M | -80.0% | |
| 5Y | $27.01M | -80.0% | |
| All | $27.01M | -80.0% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.55M | +51.9% | |
| 3Y | $3.55M | +51.9% | |
| 5Y | $2.86M | +88.6% | |
| All | $2.86M | +88.6% |
TTM D&A History
FAQ
What is the current TTM D&A of ROIV?
As of today, ROIV TTM D&A is $5.39M
What is ROIV TTM D&A most recent change?
ROIV TTM D&A was up +51.87% on September 30, 2025
What is 1-year change in ROIV TTM D&A?
ROIV TTM D&A is down -38.92% year-over-year
How far is ROIV TTM D&A from its all-time high?
ROIV TTM D&A is currently -80.05% below its historical high of $27.01M set on June 30, 2023
How does ROIV TTM D&A rank versus sector peers?
ROIV TTM D&A is higher than 62.32% of companies in Healthcare sector
When is ROIV next earnings release?
The next earnings release for ROIV is on
Data Sources & References
- ROIV Official Website roivant.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1635088/000163508825000016/0001635088-25-000016-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1635088/000114036125020715/0001140361-25-020715-index.htm
- ROIV Profile on Yahoo Finance finance.yahoo.com/quote/ROIV
- ROIV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/roiv